BioSpace News Archive

Idorsia is no longer continuing research into the use of ACT-539313 to treat binge eating disorders after failing to meet the primary endpoint in its latest trial.

Current COVID-19 booster shots have a problem: they last only about four months and appear to have limited efficacy in a vaccinated population. Clearly, a more durable approach is needed.

Bristol Myers Squibb announced it is extending and expanding its strategic partnership with Evotec in targeted protein degradation, marking its second protein degradation deal this month.

ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended March 31, 2022 after the market closes on Thursday, May 12, 2022.

The American Urological Association, in partnership with the Sexual Medicine Society of North America, released the 2022 clinical guideline for the diagnosis and management of priapism.

TriSalus Life Sciences®, an immunotherapy company on a mission to extend and improve the lives of patients living with liver and pancreatic tumors, today announced the enrollment of the first patient in its Pressure-Enabled Regional Immuno-Oncology (PERIO™-02) clinical study.

Utah Medical Products, Inc. announces that its Board of Directors approved a quarterly cash dividend of twenty-nine cents per share of common stock payable on July 6, 2022 to shareholders of record at the close of business on June 17, 2022.

PharmaJet® announced that Darin Zehrung has joined the executive leadership team as Chief Business Development Officer.

Therma Bright Inc. (TSXV: THRM) (“Therma” or the “Company”), a progressive medical device technology company, is pleased to announce that it will submit an application to Health Canada for review of the Company’s AcuVid™ COVID-19 Rapid Antigen Saliva Test for detecting SARS CoV-2 virus in saliva.

IzoView has been upgraded and reengineered to deliver a state-of-the-art breast imaging device for the future.